Fan Kongming, Li Yan, Fu Qiaofeng, Wang Jinmin, Lin Yong, Qiu Linyu, Ran Li, Yang Junli, Yang Chunyan
School of Pharmacy, Institute of Material Medica, North Sichuan Medical College, Nanchong 637100, China.
Innovative Platform of Basic Medical Sciences, School of Basic Medical Sciences, North Sichuan Medical College, Nanchong 637100, China.
Antioxidants (Basel). 2023 Jul 18;12(7):1448. doi: 10.3390/antiox12071448.
Active fractions and constituents with antioxidant and lipid-lowering activities were investigated using bio-assay-guided isolation and identification. The data showed that the antioxidant fraction of was AC50%, the main constituents of which were quercetin and isoquercitrin, by way of both ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) and bio-assay-guided purification and elucidation. Similarly, the lipid-lowering active fraction of was AC30% with the main constituents of 3,4-dihydroxybenzoic acid and quercetin 3,4'--diglucoside. Also, bio-assay-guided isolation led to the isolation and identification of five known compounds with a purity of more than 98%, and quercetin was both the best free radical scavenger and lipid-lowering constituent. Moreover, the mechanism of the lipid-lowering effect of AC30% might be its reduction in mRNA expression levels of sterol regulatory element binding protein 2 (SREBP2) and FAS gene in lipid synthesis. Otherwise, reducing the mRNA expression level of lipid synthesis genes, including SREBP1, SREBP2, fatty acid synthetase (FASN), -Hydroxy -methylglutaryl-CoA (HMGCR), stearoyl CoA desaturase 1 (SCD1), and increasing the mRNA expression level of lipid decomposition gene, such as carnitine palmitoyl transferease-1 (CPT1), might be involved in the lipid-lowering activity of quercetin. This study suggested that might be used to prevent and treat oxidative stress and dislipidemia-related disorders, including NAFLD.
采用生物活性导向分离鉴定法研究了具有抗氧化和降脂活性的活性成分。数据表明,通过超高效液相色谱-质谱联用(UPLC-MS)以及生物活性导向的纯化和鉴定,[提取物名称]的抗氧化活性部分为AC50%,其主要成分为槲皮素和异槲皮苷。同样,[提取物名称]的降脂活性部分为AC30%,主要成分为3,4-二羟基苯甲酸和槲皮素3,4'-二葡萄糖苷。此外,生物活性导向分离法还分离鉴定出5种纯度超过98%的已知化合物,且槲皮素既是最佳的自由基清除剂,也是降脂成分。此外,AC30%的降脂作用机制可能是其降低了脂质合成中固醇调节元件结合蛋白2(SREBP2)和脂肪酸合成酶(FAS)基因的mRNA表达水平。另外,槲皮素的降脂活性可能还涉及降低包括SREBP1、SREBP2、脂肪酸合成酶(FASN)、3-羟基-3-甲基戊二酰辅酶A还原酶(HMGCR)、硬脂酰辅酶A去饱和酶1(SCD1)在内的脂质合成基因的mRNA表达水平,以及提高脂质分解基因如肉碱棕榈酰转移酶-1(CPT1)的mRNA表达水平。本研究表明,[提取物名称]可用于预防和治疗氧化应激以及与血脂异常相关的疾病,包括非酒精性脂肪性肝病(NAFLD)。